SCHEMBL20038438

SCHEMBL20038438

Cc1ccc(CN2CCN(CC#N)CC2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.45
▸ LTA4H P09960 1/20 0.45
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ RET P07949 1/20 0.40
▸ HRH1 P35367 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ WNT3A P56704 1/20 0.38
▸ PRMT5 O14744 1/20 0.38
▸ WDR77 Q9BQA1 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ JAK2 O60674 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ AURKB Q96GD4 1/20 0.37
▸ CHRNB2 P17787 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20037557 0.82 LTA4H (0.42) POLBLTA4HMEN1KMT2AATM
SCHEMBL20038437 0.82 LTA4H (0.42) POLBLTA4HMEN1KMT2AATM
SCHEMBL20249393 0.81 RET (0.44) POLBLTA4HMEN1KMT2AATM
SCHEMBL26944345 0.81 KMT2A (0.46) POLBMEN1KMT2AATMHRH1
SCHEMBL1666554 0.81 ALDH1A1 (0.61) POLBMEN1KMT2AATMHRH1
SCHEMBL14308131 0.81 LMNA (0.54) MEN1KMT2AATMALDH1A1LMNA
SCHEMBL4554100 0.80 CHRNB2 (0.56) ALDH1A1CHRNB2CHRNA4
SCHEMBL12049097 0.80 CHRNB2 (0.51) MEN1KMT2AATMHRH1ALDH1A1
SCHEMBL27306249 0.80 KMT2A (0.44) POLBMEN1KMT2AATMHRH1
SCHEMBL12334539 0.79 HRH3 (0.59) MEN1KMT2AALDH1A1CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 — — EP disclosed
Send feedback